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Abstract
A 39-year-old male with a history of non-ischemic cardiomyopathy underwent a
HeartMate 3 (Abbott Laboratories) implantation. Within an hour of implantation,
low flow alarms were noted before exiting the operating room. The alarm was
secondary to acute pump thrombosis. This is the first reported case of thrombosis
immediately post-implant.
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Background
Left ventricular assist device (LVAD) thrombus can develop de novo in the VAD or
could arise elsewhere, such as in left ventricle (LV) and then extend to the VAD.1
In general, pump thrombosis is due to pump-related, patient-related or
management-related factors. Pump-related factors include interactions at the
interface between blood flow and the components of the pump. The impeller
mechanism involves interactions, which include surface interfaces, shear stress,
and stasis. For the inflow portion, thrombus formation at the cannulation site and
cannula malposition can lead to pump thrombosis. For the outflow portion, factors
include outflow graft impingement by the bend relief, graft kinking or twisting, and
obstruction of the outflow anastomosis.2 Patient-related factors include pre-existing
LV thrombus, atrial fibrillation, infection, right-sided heart failure, hypercoagulable
state or non-compliance. Management-related factors include sub-therapeutic
international normalized ratio, low flow due to low-speed setting or sub-optimal
hypertension management.2

Case Report
A 39-year-old male with multiple comorbidities, including non-ischemic
cardiomyopathy and heart failure with reduced left ventricular ejection fraction (1015%), was referred to our center for advanced heart failure therapies. He
experienced several months of progressive decline in functional status and was
found to be in cardiogenic shock. After a multidisciplinary team discussion, the
patient was deemed a suitable candidate for an LVAD implantation as a
destination therapy. His INTERMACS profile was 2 at the time of the implantation.
The pre-implant complete blood count, therapeutic activated partial thromboplastin
time, and fibrinogen were all within normal ranges. Preoperatively, the patient was
on continuous intravenous heparin, which was stopped four hours before surgery.
A thoracotomy and hemi-sternotomy approach were utilized. The LV end-diastolic
dimension via intra-operative transesophageal echocardiography (TEE) was 6.8
cm. The coring device was used to take out the apical core. There was an
adherent apical LV clot and some minor trabeculations, which were thoroughly
removed. As the heart was free of debris and any obstruction, the HeartMate 3
(HM3) was seated onto the sewing ring, and the locking mechanism was closed.
35,000 units of heparin were administered intraoperatively. Heparin was reversed
with standard protamine at the conclusion of cardiopulmonary bypass. No blood
products or pro-coagulants were administered. The patient’s HM3 implantation
was successful. At the time of implant, the LVAD speed was 5200 rpm, flow was
3.8 L/min, power was 3.5 Watts, and the pulsatility index was 4.4.
Approximately 60 minutes after the end of the surgery, low flow alarms started
without any significant change in speed and power. Intraoperative TEE was still in
place and revealed no pericardial effusion or tamponade. The HM3 cannula
position was appropriate with no septal contact (Figure 1). Maneuvers, including
the increase of ramp speed and dose of inotropes, had no effect. The patient’s
right ventricular function was adequate, but his aortic valve could not be closed.
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After sternal reopening, the absence of tamponade was confirmed, and there was
no kinking of the bend relief or the outflow graft. Given the acute change in pump
flow combined with no power changes with steady RPMs, there was a strong
suspicion of significant inlet cannula obstruction. The pump was unlocked from the
sewing ring and inspected. The inflow cannula had a fresh, nearly occlusive
thrombus present (Figure 2). The outflow side of the pump was similarly involved.
The thrombus appeared to involve all of the sintered surfaces of the pump.

Figure 1: The arrow shows the HeartMate 3 (Abbott Laboratories) cannula
position during intra-operative transesophogeal echocardiogram.

Figure 2: The arrow indicates the nearly occlusive thrombus in the HeartMate 3
left ventricular assist device system (Abbott Laboratories).
A pump exchange without reversal of heparin was performed. The thrombosed
pump was sent to the manufacturer for inspection, and no mechanical defects
were found. Postoperatively, the patient had a negative Factor V Leiden screen,
and he tested negative for hexagonal lupus anticoagulant. Normal MA kaolin, R
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kaolin, RK kaolin, K kaolin, lysis 30 and angle kaolin levels were documented two
days after surgery. The patient was discharged home on Postoperative Day 13.

Discussion
The HM3 uses a fully levitated, self-centering rotor with large blood flow pathways
(Maglev Flow Technology) that is more hemocompatible than the prior axial flow
technology that was used in the HeartMate II (HMII) device (Abbott Laboratories).
In the MOMENTUM 3 trial, there was a greater than 90% relative risk reduction of
suspected/confirmed pump thrombosis when compared to HMII.3 Moreover, in the
HM3 CE Mark study, there were no cases of pump thrombosis after two years of
follow up.4 The earliest reported cases of HM3 pump thrombosis were at
Postoperative Day 3.5,6 In one patient, apical calcium was noted intra-operatively,
and the proposed mechanism was the ingestion of some calcium from the apex
leading to misplacement of the rotor and subsequent thrombosis.5 In the other
case, the left ventricular cavity size decreased from 5.9 cm pre- operatively to 4.0
cm post-operatively, causing septal contact with the inflow cannula and eventually
pump thrombosis.6
Our patient had pump thrombosis within the first hour of implantation. There was
no apical calcium noticed before LVAD implantation and no septal contact during
intraoperative TEE. A possible etiology in this case could be a previous adherent
apical LV clot site that might have acted as a nidus for the development of a
thrombosis leading to acute pump thrombosis. Histological analysis confirmed the
presence of platelet and red blood cell deposition with very few fibrin strands,
suggestive of acute pump thrombus (Figure 3).

Figure 3: The arrow highlights the acute thrombus on histological analysis.
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This case represents a unique instance of very early pump thrombosis and should
be kept in mind if new, low flow alarms are encountered—even immediately postimplant
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